New blood tests can help diagnose Alzheimer’s. Are doctors ready for what’s next?
(By Jon Hamilton for NPR) A new generation of blood tests promises to change the way doctors diagnose and treat
Read More
Alzheimer's Treatment
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
(By Jon Hamilton for NPR) Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the
Read MoreNew Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read MoreCMS pitches expanded coverage of PET scans for Alzheimer’s disease
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read MoreWhy the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MoreHow Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read More26 state attorneys general urge Medicare to cover Alzheimer’s treatments
(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read MoreDepression And Alzheimer’s Treatments At A Crossroads
(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about
Read More